BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38892643)

  • 1. Dynamic Changes in Gut Microbiota-Derived Metabolite Trimethylamine-N-Oxide and Risk of Type 2 Diabetes Mellitus: Potential for Dietary Changes in Diabetes Prevention.
    Huang Y; Wu Y; Zhang Y; Bai H; Peng R; Ruan W; Zhang Q; Cai E; Ma M; Zhao Y; Lu Y; Zheng L
    Nutrients; 2024 May; 16(11):. PubMed ID: 38892643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-Term Changes in Gut Microbial Metabolite Trimethylamine N-Oxide and Coronary Heart Disease Risk.
    Heianza Y; Ma W; DiDonato JA; Sun Q; Rimm EB; Hu FB; Rexrode KM; Manson JE; Qi L
    J Am Coll Cardiol; 2020 Feb; 75(7):763-772. PubMed ID: 32081286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased Trimethylamine N-Oxide Portends High Mortality Risk Independent of Glycemic Control in Patients with Type 2 Diabetes Mellitus.
    Tang WH; Wang Z; Li XS; Fan Y; Li DS; Wu Y; Hazen SL
    Clin Chem; 2017 Jan; 63(1):297-306. PubMed ID: 27864387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between microbiota-dependent metabolite trimethylamine-
    Shan Z; Sun T; Huang H; Chen S; Chen L; Luo C; Yang W; Yang X; Yao P; Cheng J; Hu FB; Liu L
    Am J Clin Nutr; 2017 Sep; 106(3):888-894. PubMed ID: 28724646
    [No Abstract]   [Full Text] [Related]  

  • 5. Circulating Gut Microbiota Metabolite Trimethylamine N-Oxide (TMAO) and Changes in Bone Density in Response to Weight Loss Diets: The POUNDS Lost Trial.
    Zhou T; Heianza Y; Chen Y; Li X; Sun D; DiDonato JA; Pei X; LeBoff MS; Bray GA; Sacks FM; Qi L
    Diabetes Care; 2019 Aug; 42(8):1365-1371. PubMed ID: 31332027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dietary factors, gut microbiota, and serum trimethylamine-N-oxide associated with cardiovascular disease in the Hispanic Community Health Study/Study of Latinos.
    Mei Z; Chen GC; Wang Z; Usyk M; Yu B; Baeza YV; Humphrey G; Benitez RS; Li J; Williams-Nguyen JS; Daviglus ML; Hou L; Cai J; Zheng Y; Knight R; Burk RD; Boerwinkle E; Kaplan RC; Qi Q
    Am J Clin Nutr; 2021 Jun; 113(6):1503-1514. PubMed ID: 33709132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary Levels of Trimethylamine-N-Oxide and Incident Coronary Heart Disease: A Prospective Investigation Among Urban Chinese Adults.
    Yu D; Shu XO; Rivera ES; Zhang X; Cai Q; Calcutt MW; Xiang YB; Li H; Gao YT; Wang TJ; Zheng W
    J Am Heart Assoc; 2019 Jan; 8(1):e010606. PubMed ID: 30606084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations of serum trimethylamine N-oxide and its precursors with colorectal cancer risk in the Prostate, Lung, Colorectal, Ovarian Cancer Screening Trial Cohort.
    Byrd DA; Zouiouich S; Karwa S; Li XS; Wang Z; Sampson JN; Loftfield E; Huang WY; Hazen SL; Sinha R
    Cancer; 2024 Jun; 130(11):1982-1990. PubMed ID: 38285606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Trimethylamine N-Oxide and Related Metabolites in Plasma and Incident Type 2 Diabetes: The Cardiovascular Health Study.
    Lemaitre RN; Jensen PN; Wang Z; Fretts AM; McKnight B; Nemet I; Biggs ML; Sotoodehnia N; de Oliveira Otto MC; Psaty BM; Siscovick DS; Hazen SL; Mozaffarian D
    JAMA Netw Open; 2021 Aug; 4(8):e2122844. PubMed ID: 34448864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut microbiota-dependent trimethylamine N-oxide in acute coronary syndromes: a prognostic marker for incident cardiovascular events beyond traditional risk factors.
    Li XS; Obeid S; Klingenberg R; Gencer B; Mach F; Räber L; Windecker S; Rodondi N; Nanchen D; Muller O; Miranda MX; Matter CM; Wu Y; Li L; Wang Z; Alamri HS; Gogonea V; Chung YM; Tang WH; Hazen SL; Lüscher TF
    Eur Heart J; 2017 Mar; 38(11):814-824. PubMed ID: 28077467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut microbe-generated metabolite trimethylamine N-oxide and the risk of diabetes: A systematic review and dose-response meta-analysis.
    Zhuang R; Ge X; Han L; Yu P; Gong X; Meng Q; Zhang Y; Fan H; Zheng L; Liu Z; Zhou X
    Obes Rev; 2019 Jun; 20(6):883-894. PubMed ID: 30868721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum trimethylamine-N-oxide is associated with incident type 2 diabetes in middle-aged and older adults: a prospective cohort study.
    Li SY; Chen S; Lu XT; Fang AP; Chen YM; Huang RZ; Lin XL; Huang ZH; Ma JF; Huang BX; Zhu HL
    J Transl Med; 2022 Aug; 20(1):374. PubMed ID: 35982495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma trimethylamine N-oxide concentration is associated with choline, phospholipids, and methyl metabolism.
    Obeid R; Awwad HM; Rabagny Y; Graeber S; Herrmann W; Geisel J
    Am J Clin Nutr; 2016 Mar; 103(3):703-11. PubMed ID: 26864355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma trimethylamine N-oxide (TMAO) levels predict future risk of coronary artery disease in apparently healthy individuals in the EPIC-Norfolk prospective population study.
    Tang WHW; Li XS; Wu Y; Wang Z; Khaw KT; Wareham NJ; Nieuwdorp M; Boekholdt SM; Hazen SL
    Am Heart J; 2021 Jun; 236():80-86. PubMed ID: 33626384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gut Microbiota-Dependent Trimethylamine N-Oxide Predicts Risk of Cardiovascular Events in Patients With Stroke and Is Related to Proinflammatory Monocytes.
    Haghikia A; Li XS; Liman TG; Bledau N; Schmidt D; Zimmermann F; Kränkel N; Widera C; Sonnenschein K; Haghikia A; Weissenborn K; Fraccarollo D; Heimesaat MM; Bauersachs J; Wang Z; Zhu W; Bavendiek U; Hazen SL; Endres M; Landmesser U
    Arterioscler Thromb Vasc Biol; 2018 Sep; 38(9):2225-2235. PubMed ID: 29976769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Gut Microbiota-Related Metabolites and Type 2 Diabetes in Two Puerto Rican Cohorts.
    Sawicki CM; Pacheco LS; Rivas-Tumanyan S; Cao Z; Haslam DE; Liang L; Tucker KL; Joshipura K; Bhupathiraju SN
    Nutrients; 2024 Mar; 16(7):. PubMed ID: 38612993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations of plasma trimethylamine N-oxide, choline, carnitine, and betaine with inflammatory and cardiometabolic risk biomarkers and the fecal microbiome in the Multiethnic Cohort Adiposity Phenotype Study.
    Fu BC; Hullar MAJ; Randolph TW; Franke AA; Monroe KR; Cheng I; Wilkens LR; Shepherd JA; Madeleine MM; Le Marchand L; Lim U; Lampe JW
    Am J Clin Nutr; 2020 Jun; 111(6):1226-1234. PubMed ID: 32055828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microbiota-dependent metabolite trimethylamine-N-oxide is associated with disease severity and survival of patients with chronic heart failure.
    Trøseid M; Ueland T; Hov JR; Svardal A; Gregersen I; Dahl CP; Aakhus S; Gude E; Bjørndal B; Halvorsen B; Karlsen TH; Aukrust P; Gullestad L; Berge RK; Yndestad A
    J Intern Med; 2015 Jun; 277(6):717-26. PubMed ID: 25382824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated plasma trimethylamine-N-oxide levels are associated with diabetic retinopathy.
    Liu W; Wang C; Xia Y; Xia W; Liu G; Ren C; Gu Y; Li X; Lu P
    Acta Diabetol; 2021 Feb; 58(2):221-229. PubMed ID: 33064205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating gut microbiota metabolite trimethylamine N-oxide and oral contraceptive use in polycystic ovary syndrome.
    Eyupoglu ND; Caliskan Guzelce E; Acikgoz A; Uyanik E; Bjørndal B; Berge RK; Svardal A; Yildiz BO
    Clin Endocrinol (Oxf); 2019 Dec; 91(6):810-815. PubMed ID: 31556132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.